Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification

• Main Authors: Zhicheng Deng (Author), Guanghui Chen (Author), Yonghui Shi (Author), Ying Lin (Author), Jiebin Ou (Author), Hua Zhu (Author), Junyan Wu (Author), Guocheng Li (Author), Li Lv (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Curcumin (CUR) displays the capability of suppressing the proliferation and metastasis of various cancer cells. However, the effects and underline mechanisms of CUR to treat triple-negative breast cancer (TNBC) have not been systematically elucidated with an appropriate method.Methods: I...